Baidu Ventures has backed the small molecule cancer therapy developer’s latest round, which came after a slew of healthtech and biotech investments made by the unit in recent months.

Data storage technology producer Dera pulled in over $150m through a China Unicom-backed series C round while GlobalBees raised in excess of $110m in a round featuring SoftBank and FirstCry.

Chinese drug discovery platform QureBio raised corporate funding last week while JD.com and Qi-Anxin Technology Group were among the LPs that helped set up the $470m Shoudu Pan Healthcare Industry Fund.

Drug development platform creator Xbiome has raised nearly $100m in series B funding while bioindustrial startup services provider 21st.Bio secured a similar amount from Novo.

Corporate-backed unicorns Via and Cohesity have both confidentially filed to go public while autonomous driving technology developer Haomo.AI raised nearly $157m.

Mobile wallet developer Momo grabbed $200m in a Mizuho Bank-led round valuing it above $2bn while silicon wafer producer Mieke pulled in $188m.

China-based chipmakers Chipone Technology and Vastai Technologies raised a total of over $1.2bn while Reddit has confidentially filed to go public.

Data and analytics companies raise money in the hundreds of millions, while GV spreads investments across multiple sectors.

SoftBank invested in rounds for Olist, Open Co and Juspay while Innovaccer raised $150m.

GMG Ventures and Hearst Ventures have returned to back the data analytics service, joining financial investors such as Abrdn, which had hitherto concentrated on other asset classes.